The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Using Vibrations To Power Microelectronics
Researchers have conceptualized a strategy to harness low frequency vibrations as an infinite power source for miniature electronic devices.
Sanofi’s Dengue Vaccine Promising But Offers Incomplete Protection
A late-stage clinical trial has shown that Sanofi's dengue vaccine reduces dengue hemorrhagic fever by 89 percent but does not protect against serotype 2.
GHIT Awards Seven New Grants Amounting To US$15.3 Million
Research in the neglected tropical diseases of dengue, malaria and Chagas disease receive a US$15.3 million boost in funding from GHIT.
Phase 1/2 Results For Takeda’s Norovirus Vaccine
Takeda has announced the results of a Phase 1/2 study of its norovirus vaccine candidate which was found to be well tolerated.
Serum Institute of India Acquires Rights To German TB Vaccine
The Serum Institute of India has announced plans to take a promising new tuberculosis vaccine, developed in Germany, into the clinic.
China’s Future TB Rates Likely To Be Driven By The Elderly
TB vaccines that work well in the elderly could be key to stemming the disease in China, scientists say.
Hilleman & Gotovax Collaborate On Cholera Vaccine
The oral cholera vaccine currently in preclinical development will be cheaper, easy to administer and cross-protective for different types of bacteria.
Bridging The Gaps In Asian Vaccine Development
Countries in Asia hope that home-grown, locally manufactured vaccines will meet domestic needs, but considerable challenges stand in the way, say experts and industry leaders at the World Vaccine Congress Asia.
Takeda Invests In Vaccine Safe Co.
Alfresa's Vaccine Scheduling System helps parents keep track of their children's increasingly complex vaccination schedules.